ECHA Adds 5 SVHCs, EU Export Filing Starts Oct. 2026

On July 31, 2026, the European Chemicals Agency (ECHA) added five new substances of very high concern (SVHCs) to the candidate list, a change that directly affects export compliance for skincare OEM, cosmetics and packaging, and infant feeding and care products. Based on the update provided, any article containing any listed SVHC at or above 0.1% must be submitted to ECHA through SCIP from October 1, 2026, while non-compliant products may face customs rejection or delisting. For exporters, manufacturers, sourcing teams, and compliance functions, this is worth close attention because it shifts the issue from substance monitoring to a near-term filing and enforcement requirement under EU REACH priorities.

What Has Changed in the EU Compliance Framework

The confirmed update is that ECHA added five SVHC substances to the candidate list on July 31, 2026. The substances described in the provided summary include phthalate plasticizers and metabolites linked to newer preservative systems.

The same summary states that the change has a direct bearing on export compliance for product groups including skincare OEM, cosmetics and packaging, and infant feeding and care items.

From October 1, 2026, where any article contains any SVHC at a concentration of 0.1% or above, SCIP notification to ECHA is required. The provided information also states that products failing to comply may be refused customs clearance or removed from sale.

The update has also been incorporated into key EU REACH enforcement inspection priorities.

Where the Pressure Will Appear First

Export shipments and market access checks

From an industry perspective, exporters are likely to feel the impact first because the update is tied directly to customs clearance and market listing risk. The main operational pressure point is whether shipped articles that fall within the affected categories have been screened for the newly added SVHCs and, where relevant, prepared for SCIP notification. What deserves closer attention is the link between substance content, shipment readiness, and documentation accuracy before goods move.

Procurement and material selection in upstream supply chains

Analysis shows that sourcing and procurement teams may be affected where packaging components, additives, or other input materials could contain the newly listed SVHCs. The practical issue is not only whether a finished product is affected, but whether upstream declarations, material specifications, and supplier data are sufficiently current to identify concentrations at or above the 0.1% threshold. For companies buying materials for cosmetics packaging or infant care products, supplier communication and material traceability become more important under this change.

OEM production and product release decisions

Manufacturing and OEM operations may face tighter release review where formulations, packaging combinations, or accessory parts are supplied into EU-bound product lines. Observably, the compliance question now reaches beyond internal quality review and into whether technical files and shipment documents can support a SCIP-related filing path when required. That can affect production scheduling, export release timing, and the handling of customer compliance requests.

Distributors and downstream sales channels

For downstream channel participants, the stated risk of delisting means product continuity may depend on whether upstream partners have addressed the new candidate list update. What deserves closer attention is the flow of compliance information across the chain, especially where packaging, bundled items, or infant care accessories are involved. Even without direct manufacturing responsibility, distributors may need clearer documentary support from suppliers before placing or continuing products on the market.

Practical Priorities Before the October Filing Date

Re-check affected product and packaging scope

Analysis shows that companies should first review which exported articles may fall within the affected categories named in the update, especially skincare OEM outputs, cosmetics-related packaging, and infant feeding and care items. The immediate priority is to identify where the newly listed SVHCs could be present in articles rather than assume existing screening remains sufficient.

Update technical documents and supplier declarations

What deserves closer attention is whether current technical documentation can support a reliable SVHC assessment against the updated candidate list. This includes material declarations, test-related records where available, and supplier confirmations used in export compliance files. The provided information does not define a detailed execution method, so this should be treated as a compliance review priority rather than a confirmed uniform market practice.

Prepare for SCIP-related filing workflows

Observably, the October 1, 2026 trigger date makes internal filing readiness a near-term issue for affected exporters. Companies may need to verify which teams handle article-level data, who owns ECHA-facing submissions, and whether shipment release is linked to completion of required compliance steps. Because the input does not provide more detailed procedural guidance, the exact filing workflow still requires ongoing validation against formal implementation materials.

Watch for enforcement language in customer and trade documents

From an industry perspective, another practical point is how this update may begin to appear in customer compliance questionnaires, procurement specifications, product acceptance terms, or trade documentation. Since the update has been included in EU REACH enforcement priorities, companies should monitor whether buyers, importers, and service partners tighten documentary expectations ahead of or after October 2026.

How This Update Should Be Read Now

Analysis shows that this is better understood as a concrete compliance signal rather than a distant policy discussion. The reason is that the provided information already connects the candidate list update to a defined SCIP notification threshold, a stated start date, and explicit enforcement consequences such as customs refusal or delisting.

At the same time, it is also appropriate to treat parts of the market response as still developing. Observably, companies will still need to watch how enforcement is applied in practice, how counterparties define acceptable documentation, and whether commercial documents begin to reflect the update more explicitly. The current development therefore combines a landed rule change with execution details that still merit close observation.

What the Industry Should Take From This

The immediate significance of this development lies in how quickly a candidate list update can translate into export documentation, product screening, and shipment risk for specific consumer-facing categories. For companies connected to cosmetics, packaging, and infant care supply chains, the issue is not only substance awareness but operational readiness before goods reach the EU market.

It is more appropriate to understand this update as an active enforcement-related compliance change with short-term trade implications, while still recognizing that detailed execution practices and market reactions require continued monitoring.

Basis of This Article and What Still Needs Verification

This article is based on the user-provided news title, event date, and event summary. For developments of this kind, relevant source types typically include official agency announcements, regulator publications, customs or trade authority notices, industry association updates, standard-setting documents, and reporting by established trade media.

No specific official source link was provided in the input, so the exact official publication path still needs to be verified on an ongoing basis. Further observation is also needed regarding detailed implementation language, certification and compliance interpretation, changes in tender or procurement documents, market feedback, and how affected companies execute the requirement in practice.